Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Draft Guidance for Industry; Availability
🏛 Food and Drug Administration (FDA)FDA-2023-D-5016
Documents
1
Total comments
55
all analyzed
Comment status
Open
Last activity
Jun 24, 2026
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
OtherDec 30, 2024
Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices; Guidance for Industry - Draft GuidanceClosed on Mar 1, 2025💬 55 comments